ArticleBrain : a journal of neurology2024

Customized antisense oligonucleotide-based therapy for neurofilament-associated Charcot-Marie-Tooth disease.

Jessica Medina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.